These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2332786)

  • 21. Comparative sensitivity of penicillinase producing Staphylococcus aureus to four cephalosporin antibiotics.
    Bremner DA; Fortune J
    N Z Med J; 1975 Sep; 82(548):189-90. PubMed ID: 1059959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between plasma and tonsillar levels of cefroxadine.
    Fraschini F; Scaglione F; Vago F; Bichisao E; Borghi C; Montanari M
    Chemotherapy; 1988; 34(1):8-12. PubMed ID: 3349862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory and clinical studies cefroxadine in pediatric field (author's transl)].
    Kawamura Y; Nomura T; Ihara T; Shimizu S; Kamiya H; Sakurai M; Nishi H
    Jpn J Antibiot; 1981 Dec; 34(12):1655-62. PubMed ID: 7334590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study on a new cephalosporin: CGP 9000 (cefroxadine)].
    Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Eandi M
    Minerva Med; 1981 Apr; 72(13):813-8. PubMed ID: 7219791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New oral cephem antibiotic, cefroxadine capsules, against superficial suppurative disease in the field of surgery].
    Abe N; Sakurai K
    Jpn J Antibiot; 1983 Sep; 36(9):2515-20. PubMed ID: 6655866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Laboratory and clinical studies on cefroxadine (author's transl)].
    Nishikawa K; Aso K; Miyachi Y; Ogawa A; Yafuso M; Kuno K
    Jpn J Antibiot; 1981 Dec; 34(12):1647-54. PubMed ID: 7334589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of cefroxadine dry syrup on intestinal bacterial flora].
    Iwata S; Yokota T; Kusumoto Y; Shiro H; Sato Y; Akita H; Nanri S; Oikawa T; Kusano S; Sunakawa K
    Jpn J Antibiot; 1986 Aug; 39(8):1967-74. PubMed ID: 3540337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of cefroxadine (CGP-9000) from patients undergoing dialysis.
    Nieto MJ; Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Eur J Clin Pharmacol; 1983; 24(1):109-12. PubMed ID: 6832192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ["In vitro" activity of a new cephalosporin (CGP-7174-E or cefsulodin) against "Pseudomonas aeruginosa" (author's transl)].
    Berche P; Descamps P; Avril JL; Véron M
    Ann Microbiol (Paris); 1979; 130B(4):477-84. PubMed ID: 120122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical study of cefroxadine in the field of obstetrics and gynecology].
    Okada N; Sugimoto Y; Suno N; Shikato Y
    Jpn J Antibiot; 1983 Sep; 36(9):2556-61. PubMed ID: 6655870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical use of cefroxadine in dentistry and oral surgery].
    Kikuta T; Masuda N; Kinebuchi T; Takarada H
    Jpn J Antibiot; 1983 Aug; 36(8):2017-28. PubMed ID: 6655824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of cefroxadine dry syrup in children (author's transl)].
    Kobayashi Y; Haruta T; Kuroki S; Okura KE; Yamakawa M; Fujiwara T; Gotoh K
    Jpn J Antibiot; 1981 Dec; 34(12):1680-90. PubMed ID: 7334592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cephradine suspension infants and children.
    Ginsburg CM; McCracken GH
    Antimicrob Agents Chemother; 1979 Jul; 16(1):74-6. PubMed ID: 475377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cefroxadine in healthy volunteers and patients with impaired renal function.
    Ohkawa M; Takamae K; Shimamura M; Kuroda K; Awazu S
    Chemotherapy; 1981; 27(3):149-54. PubMed ID: 7226971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Gardnerella vaginalis to cephradine.
    Goldstein EJ; Kwok YY; Sutter VL
    Antimicrob Agents Chemother; 1983 Sep; 24(3):418-9. PubMed ID: 6605720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Laboratory and clinical studies of cefroxadine (author's transl)].
    Nishimura T; Tabuki K; Hiromatsu K; Takashima T; Kotani Y
    Jpn J Antibiot; 1981 Dec; 34(12):1634-46. PubMed ID: 7334588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro bacteriostatic and bactericidal activities of 7 cephalosporin antibiotics on Haemophilus influenzae.
    Yourassowsky E; Schoutens E
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):433-6. PubMed ID: 1081973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of uptake of cefroxadine by rabbit small intestinal brush border membrane vesicles.
    Kitagawa S; Sugaya Y
    Biol Pharm Bull; 1996 Feb; 19(2):268-73. PubMed ID: 8850320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory studies on mecillinam: activity alone and combined with cephradine.
    Kerry DW; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():53-8. PubMed ID: 587708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cefroxadine on L-leucine absorption in rat jejunum.
    Mendizabal MV; Idoate I; Jordan J; Larralde J
    Arch Int Physiol Biochim Biophys; 1991 Jun; 99(3):247-50. PubMed ID: 1717060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.